Incidence, risk factors and treatment response in patients with chronic graft versus-host disease after haploidentical transplantation with post-transplantation cyclophosphamide

被引：0
|
作者：
Rivera, Daniel [1 ]
Lopez-Corral, Lucia [1 ]
Kwon, Mi [2 ]
Bermudez, Arancha [3 ]
Yanez, Lucrecia [3 ]
Gallardo, Anabel [4 ]
Cabrero, Monica [1 ]
Champ, Diana [2 ]
Garcia-Avila, Sara [3 ]
Garcia, Abel [4 ]
Perez, Estefania [1 ]
Balsalobre, Pascual [2 ]
Colorado, Mercedes [3 ]
Jesus Pascual, Maria [4 ]
Martin, Ana [1 ]
Luis Diez, Jose [2 ]
Gayoso, Jorge [2 ]
Dolores Caballero, Maria [1 ]
机构：
[1] Hosp Univ Salamanca IBSAL, Hematol, Salamanca, Spain
[2] Hosp 12 Octubre, Hematol, Madrid, Spain
[3] Hosp Marques Valdecilla, Hematol, Santander, Spain
[4] Hosp Carlos Haya, Hematol, Malaga, Spain
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P374
引用
收藏
页码：426 / 427
页数：2
相关论文
共 50 条
  • [41] Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases
    Fernandes, Juliana Folloni
    Nichele, Samantha
    Arcuri, Leonardo Javier
    Ribeiro, Lisandro
    Zamperlini-Netto, Gabriele
    Loth, Gisele
    Melo Rodrigues, Ana Luiza
    Kuwahara, Cilmara
    Koliski, Adriana
    Trennepohl, Joanna
    Garcia, Julia Lopes
    Daudt, Liane Esteves
    Seber, Adriana
    Gomes, Alessandra Araujo
    Fasth, Anders
    Pasquini, Ricardo
    Hamerschlak, Nelson
    Rocha, Vanderson
    Bonfim, Carmem
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (10) : 1923 - 1929
  • [42] INCIDENCE AND RISK FACTORS FOR CHRONIC GRAFT-VERSUS-HOST DISEASE (cGVHD) AFTER CORD BLOOD TRANSPLANTATION (CBT)
    Saliba, R. M.
    Couriel, D.
    Komanduri, K.
    Patah, P.
    Westin, J.
    Giralt, S.
    Cooper, L.
    Petropoulos, D.
    Worth, L.
    Safdar, A.
    Champlin, R. E.
    Shpall, E. J.
    de Lima, M.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 132 - 133
  • [43] Incidence, risk factors and therapy response of acute graft-versus-host disease after myeloablative hematopoietic stem cell transplantation with posttransplant cyclophosphamide
    Canto, P. Asensi
    Gomez-Segui, I.
    Montoro, J.
    Montaner, M. Villalba
    Chorao, P.
    Alcaina, P. Solves
    Balsera, M. Santiago
    Madrid, P. Lloret
    Ruiz, J. Solis
    Pell-Ilderton, C. Sopena
    Campuzano, D. Martinez
    Serrano, P. Granados
    del Rio, J. Eiris
    Louro, A.
    Rebollar, P.
    Perla, A.
    Benavente, R.
    Comos, J. De la Rubia
    Sanz, M. A.
    Balaguer, A.
    Sanz, J.
    [J]. BONE MARROW TRANSPLANTATION, 2024,
  • [44] Post-transplantation cyclophosphamide (Cy) reduces graft rejection and graft-versus-host disease (GVHD) after non-myeloablative, partially HLA-mismatched (haploidentical) bone marrow transplantation (BMT)
    Fuchs, EJ
    Lunzik, L
    Chen, AR
    Phelps, M
    Crawford, A
    Brodsky, RA
    Jones, RJ
    [J]. BLOOD, 2004, 104 (11) : 128A - 128A
  • [45] Risk Factors for Graft-Versus-Host Disease (GVHD) in Haploidentical Hematopoietic Cell Transplantation (HCT) Using Post-Transplant Cyclophosphamide (PTCy)
    Rashidi, Armin
    Hamilton, Betty K.
    Wang, Tao
    Hemmer, Michael T.
    Spellman, Stephen R.
    Alousi, Amin M.
    Jagasia, Madan
    Pidala, Joseph A.
    Arora, Mukta
    Im, Annie P.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [46] CYTOKINE RELEASE SYNDROME IN PATIENTS UNDERGOING HAPLOIDENTICAL ALLOGENIC TRANSPLANTATION WITH POST-TRANSPLANTATION CYCLOPHOSPHAMIDE
    Solan, L.
    Landete, E.
    Losa, A.
    Dorado, N.
    Serrano, D.
    Martinez-Laperche, C.
    Anguita, J.
    Diez-Martin, J. L.
    Kwon, M.
    [J]. HAEMATOLOGICA, 2018, 103 : 34 - 35
  • [47] Risk factors for chronic graft-versus-host disease after haploidentical hematopoietic stem cell transplantation in acute myeloid leukemia
    Yu, Wen-Jing
    Mo, Xiao-Dong
    Zhang, Xiao-Hui
    Xu, Lan-Ping
    Wang, Yu
    Yan, Chen-Hua
    Chen, Huan
    Chen, Yu-Hong
    Liu, Kai-Yan
    Huang, Xiao-Jun
    [J]. BONE MARROW TRANSPLANTATION, 2019, 54 : 307 - 307
  • [48] Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis
    Hamadani, Mehdi
    Zhang, Mei-Jie
    Tang, Xiao-Ying
    Fei, Mingwei
    Brunstein, Claudio
    Chhabra, Saurabh
    D'Souza, Anita
    Milano, Filippo
    Phelan, Rachel
    Saber, Wael
    Shaw, Bronwen E.
    Weisdorf, Daniel
    Devine, Steven M.
    Horowitz, Mary M.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (07) : 1312 - 1317
  • [49] Budesonide Added to Post-Transplantation Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for Prevention of Graft-Versus-Host Disease
    Vittayawacharin, Pongthep
    Jeyakumar, Deepa
    Lee, Benjamin J.
    Doh, Jean
    Griffin, Shawn
    Van Etten, Richard A.
    Kongtim, Piyanuch
    Ciurea, Stefan
    [J]. BLOOD, 2023, 142
  • [50] Haploidentical Transplantation with PBSC Graft in Children: The Need to Look Beyond Post-Transplantation Cyclophosphamide in Younger Children
    Jaiswal, Sarita
    Chakrabarti, Aditi
    Chatterjee, Sumita
    Ray, Kunal
    Zaman, Shamsuz
    Chakrabarti, Suparno
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S250 - S250
12345